Redwood Investment Management, LLC Novartis Ag Transaction History

Redwood Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $567,224 - $627,221	-7,117 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $594,269 - $700,810	7,117 New	7,117 $608,000
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $427,553 - $599,010	-6,050 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $8,181 - $9,250	97 Added 1.63%	6,050 $573,000
Q3 2019 Nov 18, 2019	BUY	$85.54 - $94.26 $75,018 - $82,666	877 Added 17.28%	5,953 $517,000
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $66,125 - $81,385	-877 Reduced 14.73%	5,076 $488,000
Q2 2019 Aug 15, 2019	BUY	$75.4 - $92.8 $66,125 - $81,385	877 Added 17.28%	5,953 $544,000
Q1 2019 May 16, 2019	BUY	$75.32 - $86.15 $382,324 - $437,297	5,076 New	5,076 $488,000
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $223,699 - $267,428	-3,178 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $229,864 - $246,739	3,178	3,178 $267,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investment Management, LLC with notifications on news.